Carlos Eduardo Brandao-Mello
Overview
Explore the profile of Carlos Eduardo Brandao-Mello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flores G, Lago B, Caetano A, Silva J, Marques V, Brandao-Mello C, et al.
Braz J Infect Dis
. 2025 Feb;
29(2):104512.
PMID: 39985934
Background: Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) share the same routes of transmission, therefore, co-infection by both viruses represents a challenge to the goal of eliminating viral hepatitis...
2.
Maciel A, Ferraz M, Perez R, Brandao-Mello C
Eur J Gastroenterol Hepatol
. 2024 Feb;
36(4):482-488.
PMID: 38407882
Objectives: To analyze the evolution of glomerular filtration rate (GFR) and the presence of renal tubular dysfunction during the treatment of chronic hepatitis B virus (HBV) infection with tenofovir disoproxil...
3.
Amendola-Pires M, Fakoury M, Salazar H, De Oliveira S, Brandao-Mello C, Schmidt S
J Clin Med
. 2023 Jun;
12(12).
PMID: 37373605
Hepatitis C virus (HCV) infection is a leading cause of liver cirrhosis, hepatocellular carcinoma, and liver-related deaths. It is estimated that 40-74% of patients with hepatitis C will experience at...
4.
Chagas A, Leal C, Mello V, Barros F, Bittencourt P, Mattos A, et al.
Arq Gastroenterol
. 2023 May;
60(1):106-131.
PMID: 37194769
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality worldwide. The Brazilian Society of Hepatology (SBH) published in 2020 the updated recommendations for the diagnosis and treatment...
5.
Villela-Nogueira C, Ferraz M, Pessoa M, Souto F, Cancella Nabuco L, Coelho H, et al.
Ann Hepatol
. 2022 Oct;
28(1):100764.
PMID: 36182033
Introduction And Objectives: The Choosing Wisely (CW) initiative aims to improve daily practice supported by evidence concerning unnecessary medical tests, procedures, and treatments. This philosophy is essential in managing viral...
6.
Abrantes J, Torres D, Brandao-Mello C
Int J Hepatol
. 2021 Jun;
2021:8823676.
PMID: 34113467
Several studies have proposed a link between chronic hepatitis C virus (HCV) infection and the development of cognitive disorders. However, the inclusion of confounding factors in their samples significantly limits...
7.
Flores G, Barbosa J, Cruz H, Miguel J, Potsch D, Pilotto J, et al.
World J Hepatol
. 2021 May;
13(4):504-514.
PMID: 33959230
Background: To achieve the elimination of hepatitis B and C, there is an urgent need to develop alternative strategies to increase the access of diagnosis, particularly among key populations such...
8.
Machado S, Vigani A, Leite A, Diaz A, Ferreira P, Carnauba-Junior D, et al.
Medicine (Baltimore)
. 2020 Aug;
99(30):e21270.
PMID: 32791706
In a hepatitis C virus (HCV)/HIV-positive Brazilian cohort, evaluate the safety and efficacy of HCV DAAs, the frequency of resistance substitutions in the HCV NS5A and NS5B genes and identify...
9.
Torres D, Abrantes J, Brandao-Mello C
Sci Rep
. 2020 May;
10(1):8610.
PMID: 32451417
Minimal hepatic encephalopathy is a syndrome caused by cirrhosis, with a broad spectrum of clinical manifestations. Its diagnosis is based on abnormal results of cognitive and neurophysiological tests, but there...
10.
Abrantes J, Torres D, Brandao-Mello C
Int J Hepatol
. 2020 Apr;
2020:9675235.
PMID: 32257447
Since the discovery of HCV in 1989, several diseases have been related to chronic infection by this virus. Often, patients with hepatitis C virus (HCV) complain of cognitive impairment even...